Skip to main content
. 2021 Nov 20;67(8):3831–3841. doi: 10.1007/s10620-021-07299-2

Table 1.

Select baseline participant characteristics by HCC development

Total n = 227 Did not Develop HCC (n = 213) Developed HCC (n = 14) p-value
Mean (SD) or n (%) Mean (SD) or n (%)
Age (yr) (mean) 59.4 (12.4) 61.4 (10.0) 0.60
Site
CS 96 (45.1) 9 (64.3) 0.37
UC 55 (25.8) 2 (14.3)
VA 62 (29.1) 3 (21.4)
Sex
Male 141 (66.2) 13 (92.9) 0.04
Female 72 (33.8) 1 (7.1)
Race
White 177 (83.1) 11 (78.6) 0.60
African American 18 (8.5) 2 (14.3)
Asian 11 (5.2) 1 (7.1)
Other 7 (3.3) 0 (0.0)
Ethnicity
Non-Hispanic/Latinx 134 (62.9) 9 (64.3) 1.00
Hispanic or Latinx 79 (37.1) 5 (35.7)
Etiology of Cirrhosis
HCV 66 (31.0) 7 (50.0) 0.49
Alcohol 56 (26.3) 2 (14.3)
HBV 6 (2.8) 1 (7.1)
NAFLD 46 (21.6) 2 (14.3)
Other 39 (18.3) 2 (14.3)
Complication of cirrhosis
HE
No 160 (75.1) 7 (50.0) 0.04
Yes 53 (24.9) 7 (50.0)
Varices
No 86 (40.4) 4 (28.6) 0.26
Yes 127 (59.6) 10 (71.4)
Ascites
No 119 (55.9) 8 (57.1) 1.00
Yes 94 (44.1) 6 (42.9)
At Least 1 Complication
No 61 (28.6) 3 (21.4) 0.76
Yes 152 (71.4) 11 (78.6)
Diabetes
No 161 (75.6) 11 (78.6) 1.00
Yes 52 (24.4) 3 (21.4)
AFP (ng/mL) (mean) 5.13 (21.96) 4.25 (3.56) 0.88
MELD (mean) 9.7 (6.1) 10.9 (7.8) 0.46